SU2C

4 Apr 2019

Blocking epigenetic “Swiss army knife” may be a new strategy for treating colorectal cancer

/

TagsBaylin, cancer, cancer research, Rothbart, SU2C, VARI, VARI-SU2C

GRAND RAPIDS, Mich. (April 4, 2019) — A new study out today in Cancer Cell shows that blocking specific regions of a...

ABOUT VAI

Established by Jay and Betty Van Andel in 1996, Van Andel Institute's goal is to have an impact world-wide on biomedical research and science education.

EMAIL UPDATES

First Name
Last Name
Email Address
Comments
This field is for validation purposes and should be left unchanged.

RECENT NEWS

American Cancer Society grant to support Van Andel Institute research into anti-cancer medications
Coriell Institute for Medical Research, Van Andel Institute awarded estimated $12.4 million SPORE grant from National Cancer Institute
Graduate student spotlight: How molecular ‘punctuation marks’ influence cancer and other diseases

Donate Contact Us Compliance EthicsPoint Intranet Privacy Policy Terms of Use